Figure 4—figure supplement 1.

Inhibiting hemodynamic flow perturbs post-injury re-activation of cardiac factors.

Whole-mount in situ hybridizations show increased (A) gata4 (n = 9/11), (E) hand2 (n = 10/10) and (I) nkx2.5 (n = 7/8) expression in vmhc:mCherry-NTR ventricle-ablated (ethanol/EtOH-treated) control hearts at 48 hpt (7 dpf). However, these cardiogenesis factors fail to increase after ventricle-ablation in (B, F, J) blebbistatin (Blebb) (n = 0/13 gata4; n = 1/10 hand2; n = 0/10 nkx2.5) or (C, G, K) tricaine (Tric) (n = 0/14 gata4; n = 2/10 hand2; n = 0/6 nkx2.5) treated hearts as well as in (D, H, L) gata2a-/- hearts (n = 5/17 gata4; n = 4/11 hand2; n = 2/7 nkx2.5). V, ventricle; A, atrium; dpf, days post-fertilization; hpt, hours post-DMSO treatment. Dashed lines outline the heart. Bars: 50 μm.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Elife